![Mark W. Womack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark W. Womack
Verkställande Direktör på
Selexis SA
Profil
Mark W.
Womack is currently Chief Executive Officer at Selexis SA since 2022.
Formerly, Mr. Womack was Chief Executive Officer at KBI Biopharma, Inc. from 2022 to 2023, Chief Executive Officer at OneSource Specialty Pharma Ltd., Chief Executive Officer at BioCina Pty Ltd. from 2023 to 2025, and Chief Business Officer at AGC Biologics, Inc.
Aktiva positioner av Mark W. Womack
| Företag | Position | Start |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Verkställande Direktör | 2022-05-02 |
Tidigare kända positioner av Mark W. Womack
| Företag | Position | Slut |
|---|---|---|
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Verkställande Direktör | 2023-04-17 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Verkställande Direktör | - |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Företagsledare/Principal | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
9
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Commercial Services |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
